Log in to save to my catalogue

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2440663082

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

About this item

Full title

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

Publisher

Cham: Springer International Publishing

Journal title

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-10, Vol.34 (5), p.543-556

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive lung scarring due to unknown injurious stimuli ultimately leading to respiratory failure. Diagnosis is complex and requires a combination of clinical, laboratory, radiological, and histological investigations, along with exclusion of known causes of lung fibro...

Alternative Titles

Full title

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2440663082

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2440663082

Other Identifiers

ISSN

1173-8804,1179-190X

E-ISSN

1179-190X

DOI

10.1007/s40259-020-00437-8

How to access this item